Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-09

FDA Approved: PARICALCITOL — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Amneal Pharmaceuticals LLC's original ANDA for PARICALCITOL, a generic paricalcitol product for treating secondary hyperparathyroidism in adults wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paricalcitol (paricalcitol)

Snippet

ORIG AP for PARICALCITOL (PARICALCITOL)